Skip to content

Agenda

11:30 am – 12:30 pm General Registration Check-in & Networking Lunch
Hosted By:
Aerie
12:30 – 12:45 pm Welcome & Retinal Innovation Highlights
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
12:45 – 1:45 pm Retina Company Showcase
Moderated By:
Tracy Saxton, PhD, Investment Director – Roche Venture Fund

Company Presentations:
1:45 – 2:15 pm Networking Break
2:15 pm Financing Environment
Introduced By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
2:15 – 2:22 pm Trends in Private Company Financing & Exits in Ophthalmology
Jonathan Norris, Managing Director – Silicon Valley Bank
2:22 – 2:30 pm Public Market Trends in Ophthalmology
Andrew Gitkin, Head, West Coast Investment Banking – Piper Jaffray
2:30 – 3:00 pm Innovation in Retinal Imaging: Opportunities & Challenges
Presentations

Introduced by:
William J. Link, PhD, Managing Director – Versant Ventures

Presenters:

Panel Discussion

Moderated By:
William J. Link, PhD, Managing Director – Versant Ventures

Participants:
Ryan Bouchard, Director, Medical Devices – Ora
Heinrich Dreyer, PhD, VP, Medical Division – Leica Microsystems
Ralf Kuschnereit, PhD, SVP Ophthalmic Systems Division – Carl Zeiss Meditec AG
Kester Nahen, PhD, Managing Director – Heidelberg Engineering

3:00 – 3:30 pm Paying for Breakthrough Eye Therapies (Biologics, Biosimilars & Gene Therapies)
Company Presentations

Moderated By:
Tarek Hassan, MD

Presenters:

Panel Discussion

Co-Moderated By:
Tarek Hassan, MD
Gilbert H. Kliman, MD, Managing Director – InterWest Partners

Participants:
Jay Duker, MD
Joshua Schimmer, Senior Research Analyst – Piper Jaffray
John Thompson, MD
Trex Topping, MD

3:30 – 3:50 pm Networking Break
3:50 – 4:30 pm Emerging Approaches to Combination Therapies in AMD & DME
Company Presentations

Moderated By:
Mark Humayun, MD

Presenters:

Panel Discussion:

Co-Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
Mark Humayun, MD

Participants:
Mark Blumenkranz, MD
Adnan Butt, Biotech Analyst – RBC Capital Markets
Donald D’Amico, MD
Pravin Dugel, MD
Peter Kaiser, MD

4:30 – 5:10 pm Masters of the Industry
Moderated By:
Jim Mazzo, Global President of Ophthalmology – Carl Zeiss Meditec

Participants:
Tony Adamis, MD, Global Head, I2O & Metabolism, Clinical Science – Genentech
Frederic Guerard, Worldwide Business Franchise Head, Ophthalmology – Alcon
William J. Link, PhD, Managing Director – Versant Ventures
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG

5:10 – 5:15 pm Closing Remarks
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
5:15 – 6:15 pm Networking Reception
Hosted By:
Ora
Scroll To Top